I think they started with conservative estimates. As more and more surgeons have adopted the product, they've seen their willingness to use Novosorb in a wide range of cases - more quickly than they expected. So while there may have been some conservatism built into the estimates of the market, perhaps assuming some may view it as a niche product, real world evidence has suggested otherwise. Surgeons can see how good and easy it is to use, and are willing to use it in a range of surgeries.
I've done a lot of stalking and I've yet to find a single surgeon who has come out and said that a competitor's product is better, or that they think Novosorb will only be useful for X & Y procedures. Just my opinion, but I'd guess most of them are thinking about other procedures they could use it in after they've used it in just a handful of procedures.
- Forums
- ASX - By Stock
- PNV
- Ann: Trading Update
Ann: Trading Update, page-140
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.36 |
Change
0.050(2.16%) |
Mkt cap ! $1.628B |
Open | High | Low | Value | Volume |
$2.33 | $2.39 | $2.33 | $2.230M | 946.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3861 | $2.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 20817 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3861 | 2.360 |
6 | 24029 | 2.350 |
6 | 17119 | 2.340 |
6 | 29393 | 2.330 |
5 | 12565 | 2.320 |
Price($) | Vol. | No. |
---|---|---|
2.380 | 20817 | 3 |
2.390 | 2864 | 1 |
2.400 | 22173 | 6 |
2.410 | 43605 | 3 |
2.420 | 2877 | 1 |
Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
PNV (ASX) Chart |